Ascella Biosystems
San Francisco, US · Founded 2020 · Delaware corporation
Founders & leadership
JK
JUNICHI KAJIMOTONamed on SEC filing
SI
SATORU IINONamed on SEC filing
DB
DEEPAK BOGGAVARAPUNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.3M disclosed across 1 round · 2023
▶$6.3MraisedDec 2023 · 11 investors · Other Health CareRule 506(b)
▶$6.3MraisedDec 2023 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JUNICHI KAJIMOTOExecutive Officer, Director
- SATORU IINODirector
- DEEPAK BOGGAVARAPUExecutive Officer, Director, Promoter
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ascella Biosystems raised?
- Ascella Biosystems has disclosed $6.3M raised across 1 round.
- Where is Ascella Biosystems headquartered?
- Ascella Biosystems is headquartered in San Francisco, US.